SCAMP5 and diabetes mellitus: Thus, inhibiting VDAC1 presents a potential therapeutic strategy for diabetes management.[17] Our data demonstrate that SCAMP5 negatively regulates the expression of VDAC1: Deficiency of SCAMP5 upregulates, whereas elevated SCAMP5 suppresses VDAC1 expression in β‐cells.